Half year results: portfolio makes significant commercial and technical progress
Frontier IP and our portfolio companies attracted major industry interest during the first half of the year, despite difficult markets impacting the financial results.
Read moreAlusid extends product range in collaboration with world leader Imerys
Alusid has successfully collaborated with world-leading specialty minerals group Imerys to create floor tiles after becoming one of two winners in a global competition.
Read moreCelerum appoints Chief Executive Officer
Celerum has appointed David Gladding, who has more than 30 years’ experience at senior levels in software and IT services companies as CEO.
Read moreDARPA-funded TVG project develops transmissible Lassa fever vaccine candidate
Trial of transmissible Lassa fever candidate vaccine for use in rats to reduce its the threat to humans as part of project funded by the US Defense Advanced Research Projects Agency.
Read moreTVG successfully completes Anglo-Chinese pig vaccine project
The Company has developed a vaccine candidate to tackle Streptococcus suis, a disease endemic in the global pig population. It can also jump to humans, causing meningitis and septicaemia. The project was backed by the UK Department of Health and Social Care, Innovate UK and the Chinese Ministry of Science and Technology.
Read morePulsiv raises £1.5 million in equity funding round
Our portfolio company Pulsiv has raised £1.5 million to support further commercialisation of its ground-breaking, high-efficiency power conversion technology.
Read moreFinal results: portfolio equity value up 24 per cent to £39.7 million
A landmark year saw our first partial exit after Exscientia listed on Nasdaq and the rest of the portfolio performed strongly. Pre-tax profits rose to £10.9 million
Read morePulsiv unveils world-leading electronics technology to cut energy consumption
Our portfolio company Pulsiv has launched Pulsiv OSMIUM, a new technology to significantly improve the energy efficiency of power supplies and battery chargers.
Read moreSir Michael Rake to join CamGraPhIC board as company raises £1.26 million
Former BT Group chairman and CamGraPhIC investor will join board by the end of the year. The company has also raised £1.26 million to support scale up, of its graphene-based photonics technology.
Read moreCambridge Raman Imaging raises £1.1 million to accelerate scale up
Cambridge Raman Imaging is to use proceeds to further develop first commercial prototype of Raman imaging microscope and artificial intelligence to support disease diagnosis and treatment.
Read more